Clinical trial

Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy

NCT01664663

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2011-09-01

PhasePHASE2

Study timeline

Study start (unknown)2011-09-01Date precision: month

Registry last updated2014-12-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Locally Advanced Diseaseunresolved

Interventions

Standard radiochemotherapy to 68 GyRADIATION

Dose escalated radiochemotherapy up to 84 GyRADIATION

Sponsors & collaborators

Ass. Prof. Jan Nymanlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01664663 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.